Literature DB >> 15489963

Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.

Supriya Srinivasan1, Cecile Lubrano-Berthelier, Cedric Govaerts, Franck Picard, Pamela Santiago, Bruce R Conklin, Christian Vaisse.   

Abstract

The melanocortin-4 receptor (MC4R), a centrally expressed G protein-coupled receptor (GPCR), is essential for the maintenance of long-term energy balance in humans. Mutations in MC4R are the most common genetic cause of obesity. Since activation of this receptor leads to a decrease in food intake, MC4R is also a major therapeutic target for the treatment of obesity. Control of MC4R activity in vivo is modulated by the opposing effects of the anorexigenic agonist alpha-melanocyte-stimulating hormone (alpha-MSH) and the orexigenic antagonist agouti-related protein (AGRP). In addition, experiments in vitro have demonstrated that the human MC4R has an intrinsic constitutive activity on which AGRP also acts as an inverse agonist. The physiological role of this constitutive activity in the control of energy balance as well as the domain of the protein implicated in its maintenance are unknown. By systematically studying functional defects in naturally occurring MC4R mutations from obese patients, we defined a cluster of N-terminal mutations that selectively impair the constitutive activity of the receptor. Further characterization of this domain demonstrated that it functions as a tethered intramolecular ligand that maintains the constitutive activity of MC4R and may provide novel avenues for the design of drugs targeting this receptor. Our results also suggest that the tonic satiety signal provided by the constitutive activity of MC4R may be required for maintaining long-term energy homeostasis in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489963      PMCID: PMC522250          DOI: 10.1172/JCI21927

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Neuroscience. The fat-brain axis enters a new dimension.

Authors:  Joel K Elmquist; Jeffrey S Flier
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

2.  Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene.

Authors:  R S Jackson; J W Creemers; S Ohagi; M L Raffin-Sanson; L Sanders; C T Montague; J C Hutton; S O'Rahilly
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

3.  Congenital leptin deficiency is associated with severe early-onset obesity in humans.

Authors:  C T Montague; I S Farooqi; J P Whitehead; M A Soos; H Rau; N J Wareham; C P Sewter; J E Digby; S N Mohammed; J A Hurst; C H Cheetham; A R Earley; A H Barnett; J B Prins; S O'Rahilly
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

4.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

5.  Molecular cloning, expression, and gene localization of a fourth melanocortin receptor.

Authors:  I Gantz; H Miwa; Y Konda; Y Shimoto; T Tashiro; S J Watson; J DelValle; T Yamada
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

6.  Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

Authors:  B G Challis; A P Coll; G S H Yeo; S B Pinnock; S L Dickson; R R Thresher; J Dixon; D Zahn; J J Rochford; A White; R L Oliver; G Millington; S A Aparicio; W H Colledge; A P Russ; M B Carlton; S O'Rahilly
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

7.  Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode.

Authors:  J Chen; M Ishii; L Wang; K Ishii; S R Coughlin
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

8.  The human MC4R promoter: characterization and role in obesity.

Authors:  Cecile Lubrano-Berthelier; Martha Cavazos; Catherine Le Stunff; Kurt Haas; Astrid Shapiro; Sumei Zhang; Pierre Bougneres; Christian Vaisse
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

9.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

Authors:  K G Mountjoy; M T Mortrud; M J Low; R B Simerly; R D Cone
Journal:  Mol Endocrinol       Date:  1994-10

10.  Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cells.

Authors:  J Van Sande; M J Costa; C Massart; S Swillens; S Costagliola; J Orgiazzi; J E Dumont
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

View more
  75 in total

1.  Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

Review 2.  New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.

Authors:  J K L Walker; R B Penn; N A Hanania; B F Dickey; R A Bond
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

3.  Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR.

Authors:  Baran A Ersoy; Leonardo Pardo; Sumei Zhang; Darren A Thompson; Glenn Millhauser; Cedric Govaerts; Christian Vaisse
Journal:  Nat Chem Biol       Date:  2012-06-24       Impact factor: 15.040

4.  Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.

Authors:  Irina D Pogozheva; Biao-Xin Chai; Andrei L Lomize; Tung M Fong; David H Weinberg; Ravi P Nargund; Michael W Mulholland; Ira Gantz; Henry I Mosberg
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

5.  Phosphodiesterase inhibitor-dependent inverse agonism of agouti-related protein on melanocortin 4 receptor in sea bass (Dicentrarchus labrax).

Authors:  Elisa Sánchez; Vera Cruz Rubio; Darren Thompson; Juriaan Metz; Gert Flik; Glenn L Millhauser; José Miguel Cerdá-Reverter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

Review 6.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

7.  Agnostic about in vivo inverse agonism of agouti-related peptide.

Authors:  Malcolm J Low
Journal:  Endocrinology       Date:  2011-05       Impact factor: 4.736

Review 8.  Engineering GPCR signaling pathways with RASSLs.

Authors:  Bruce R Conklin; Edward C Hsiao; Sylvie Claeysen; Aline Dumuis; Supriya Srinivasan; John R Forsayeth; Jean-Marc Guettier; W C Chang; Ying Pei; Ken D McCarthy; Robert A Nissenson; Jürgen Wess; Joël Bockaert; Bryan L Roth
Journal:  Nat Methods       Date:  2008-08       Impact factor: 28.547

9.  Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor.

Authors:  Gunnar Kleinau; Holger Jaeschke; Sandra Mueller; Bruce M Raaka; Susanne Neumann; Ralf Paschke; Gerd Krause
Journal:  FASEB J       Date:  2008-04-01       Impact factor: 5.191

10.  An essential role for the K+-dependent Na+/Ca2+-exchanger, NCKX4, in melanocortin-4-receptor-dependent satiety.

Authors:  Xiao-Fang Li; Jonathan Lytton
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.